Content provided in partnership with

Business Services Industry

Synergetics USA, Inc. Retains Cameron Associates, Inc. as Investor Relations Advisor

Business Wire, May 7, 2008

O'FALLON, Mo. -- Synergetics USA, Inc. (NASDAQ: SURG), a leading microsurgery company that designs, manufactures, and markets medical devices for use primarily in ophthalmic surgery and neurosurgery, announced today that it has retained Cameron Associates, Inc., a premier full-service investor relations firm founded in 1976, as its investor relations advisor.

Cameron has a wealth of experience representing emerging companies in the U.S. and will assist Synergetics USA, Inc. in broadening its financial market presence and establishing new relationships within the investment community. Additional information about Cameron Associates, Inc. can be found on that company's web site at www.cameronassoc.com.

Most Popular Articles in Business: Research and Markets : Tesco Plc - SWOT Framework Analysis; Do Us a Flavor - Ben & Jerry's Issues a Call for Euphoric New Flavors; eBay made easy: ready to start an eBay business? These 5 simple steps will ...; Katrina's lawsuit surge: a legal battle to force insurers to pay for flood ...; Wal-Mart's newest distribution center opened last month near the southwest ...; More »

"Synergetics has made great strides in improving its overall corporate performance and is on track to continue its growth strategy," stated Al Palombo, Vice President of Cameron Associates. "This is reflected in the Company's ongoing success in cost savings initiatives and their drive for consistent top and bottom line growth. Through a process of exemplary product development, continued improvement, and a complete refocus of the Company's sales and marketing strategy, Synergetics' management has laid the foundation on which its ongoing value proposition will be built. Their business strategy is compelling and it will be a pleasure to assist Synergetics in bringing news of their progress to the institutional shareholder community."

Gregg D. Scheller, President and Chief Executive Officer of Synergetics USA, Inc. "We are excited for the future and we believe that the significant strategic, operational, and sales and marketing improvements achieved to date will translate into measurable success and meaningful shareholder value going forward. We expect our relationship with Cameron Associates will help us better communicate our progress to a wider investor audience, while providing increased corporate transparency to the general public. As we execute our business strategy, we believe that Cameron's experience and knowledge of the investment industry will serve our organization and its shareholders well."

Recent Company Highlights:

April 17, 2008:

SYNERGETICS USA, INC. INITIATES ANTITRUST LAWSUIT AGAINST ALCON, INC. - Synergetics announced that it has filed an antitrust lawsuit against Alcon, Inc. (NYSE: ACL) for its unfair practices in relation to its monopoly power in the vitrectomy machine market. Synergetics is represented by Hanly Conroy Bierstein Sheridan Fisher & Hayes, LLP and SimmonsCooper LLC, who have agreed to represent the Company on a contingency-fee basis.

March 31, 2008:

SYNERGETICS USA, INC. MERGES ITS PHILADELPHIA PRODUCTION PLANT INTO ITS O'FALLON FACILITY - The move is designed to achieve over $1.5 million in annual cost savings.

March 11, 2008:

SYNERGETICS DELIVERS RECORD Q2-08 REVENUE - Synergetics announced second quarter 2008 results reaching a quarterly net revenue record for the second quarter of $11.6 million. The Company saw revenue increases for the quarter of 15.2% in the ophthalmic business and 20.0% in neurosurgical products.

November 9, 2007:

SYNERGETICS HIRES NEW EXECUTIVE VICE PRESIDENT OF SALES AND MARKETING - Dave Dallam, former Vice President and North American General Manager for Leica Microsystems, the world leader in surgical microscopes for both ophthalmic and neurosurgical applications, joins the Synergetics' team. Under Dallam's leadership, Leica's sales more than tripled and gross profit margin percentage doubled.

About Synergetics USA, Inc.

Synergetics USA, Inc. is a leading medical device company focused on progressing the standard of care for microsurgeons and their patients by seeking to improve surgical patient outcomes through the delivery of innovative improvements in quality, delivery and cost. The Company focuses on the vitreoretinal, neurosurgery and ear, nose and throat surgery markets. The distribution channels include a combination of direct and independent sales organizations, and important strategic alliances with market leaders.

Forward-Looking Statements

Some statements in this release may be "forward-looking statements" for the purposes of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by words such as "believe," "expect," "anticipate," "plan," "potential," "continue" or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important facts that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These facts, risks and uncertainties are discussed in Synergetics' Annual Report on Form 10-K for the year ended July 31, 2007, as updated from time to time in our filings with the Securities and Exchange Commission.

Business Services Industry

Synergetics USA, Inc. Retains Cameron Associates, Inc. as Investor Relations Advisor

Business Wire, May 7, 2008

Find Research Guides for:

Find Featured Titles for: Technology

Most Popular Articles in Business

Most Popular Publications in Business